77673792 - OCQUILA

Information

  • Trademark
  • 77673792
  • Serial Number
    77673792
  • Registration Number
    3949710
  • Filing Date
    February 19, 2009
    15 years ago
  • Registration Date
    April 26, 2011
    13 years ago
  • Transaction Date
    January 09, 2018
    7 years ago
  • Status Date
    December 01, 2017
    7 years ago
  • Published for Opposition Date
    February 08, 2011
    13 years ago
  • Location Date
    April 26, 2011
    13 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    HUGHITT, ELIZABETH A
  • Attorney Docket Number
    14059
    Attorney Name
    Howard N. Aronson
    Law Office Assigned Location Code
    M20
  • Owners
Mark Drawing Code
4000
Mark Identification
OCQUILA
Case File Statements
  • GS0011: Chemicals for use in industry and science; enzymes for scientific and research purposes; biochemicals, namely, precursors for in vitro genetic engineering use; biochemicals, namely, polypeptides for in vitro research use; biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; chemicals for use in the purification of proteins for in vitro use; diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; laboratory chemicals, namely, an antibody reagent used for the detection of antigens in cell and tissue analysis for in vitro diagnostic use; micro-organisms for laboratory and scientific research use, viruses for laboratory and scientific research use, cell cultures for laboratory and scientific research use, plasmids and cultures of micro-organisms for laboratory and scientific research use, nucleic acid sequences for laboratory and scientific research use, cloning vehicles in the nature of plasmids, microbes and chemical reagents for DNA cloning for laboratory and scientific research use, chemicals for laboratory and scientific research and development use in biotechnology research and development and recombinant nucleic acid variations thereof for laboratory and scientific research use, all of the foregoing for in-vivo use
  • GS0051: Gene therapy and prophylactic products, namely, gene delivery pharmaceuticals; small molecules, vaccines, biologics, enzymes and enzyme preparations all for medical purposes in connection with gene therapy, pharmaceuticals for medical purposes for the delivery of genes to cells; viral, retroviral and non-viral vectors, and manufacturing preparations for viral, retroviral and non-viral vectors, all for medical purposes in gene therapy; biochemical and chemical preparations for medical purposes in gene therapy; pharmaceutical and biochemical preparations for the treatment or prevention of cancer, infectious disease, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases and reproductive system disorders; pharmaceutical and biochemical preparations for contraceptive purposes
  • GS0101: Instruments and apparatus for the administration of pharmaceutical, gene therapy and/or vaccine preparations and substances, namely, pre-filled vials, syringes and injectors for medical purposes
  • GS0421: Scientific, pharmaceutical and medical research and development; genetic engineering services, biotechnology services, namely, research and development of new products in the field of biotechnology, advisory services relating to the research and development of gene therapy products and clinical trials, conducting clinical trials
  • GS0441: Medical services; advisory services relating to vaccination regimens; advisory services relating to the treatment, relief and/or prevention of cancer, infectious diseases, fungal diseases, disease caused by parasites, eye disease, diseases of the central and peripheral nervous systems, cardiovascular disease, diseases affecting the immune system, inflammatory diseases, inherited disease, single gene disorders, diseases of the mouth, teeth, skin, hair and ear, bone and blood diseases, reproductive system disorders, in humans and animals, and advisory services relating to the use of pharmaceutical and biochemical preparations for contraceptive purposes, in humans and animals
Case File Event Statements
  • 12/1/2017 - 7 years ago
    26 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 4/26/2011 - 13 years ago
    25 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/8/2011 - 13 years ago
    24 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 2/8/2011 - 13 years ago
    23 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/6/2011 - 14 years ago
    22 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 1/5/2011 - 14 years ago
    21 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/5/2011 - 14 years ago
    20 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/5/2011 - 14 years ago
    19 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/4/2011 - 14 years ago
    18 - ASSIGNED TO LIE Type: ALIE
  • 12/7/2010 - 14 years ago
    17 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 6/7/2010 - 14 years ago
    16 - NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED Type: GNS2
  • 6/7/2010 - 14 years ago
    15 - INQUIRY TO SUSPENSION E-MAILED Type: GNSI
  • 6/7/2010 - 14 years ago
    14 - SUSPENSION INQUIRY WRITTEN Type: CNSI
  • 12/1/2009 - 15 years ago
    13 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 12/1/2009 - 15 years ago
    12 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 12/1/2009 - 15 years ago
    11 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 11/20/2009 - 15 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/20/2009 - 15 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/20/2009 - 15 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 11/9/2009 - 15 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 5/18/2009 - 15 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 5/18/2009 - 15 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 5/18/2009 - 15 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 5/11/2009 - 15 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/23/2009 - 15 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/23/2009 - 15 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP